Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Payables (2016 - 2025)

Eastman Chemical (EMN) has disclosed Payables for 17 consecutive years, with $2.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 2.07% year-over-year to $2.7 billion, compared with a TTM value of $2.7 billion through Dec 2025, down 2.07%, and an annual FY2025 reading of $2.7 billion, down 2.07% over the prior year.
  • Payables was $2.7 billion for Q4 2025 at Eastman Chemical, up from $2.2 billion in the prior quarter.
  • Across five years, Payables topped out at $3.3 billion in Q4 2022 and bottomed at $2.0 billion in Q1 2021.
  • Average Payables over 5 years is $2.7 billion, with a median of $2.7 billion recorded in 2024.
  • The sharpest move saw Payables skyrocketed 68.59% in 2021, then fell 20.76% in 2023.
  • Year by year, Payables stood at $2.9 billion in 2021, then rose by 12.88% to $3.3 billion in 2022, then decreased by 20.76% to $2.6 billion in 2023, then grew by 5.12% to $2.7 billion in 2024, then fell by 2.07% to $2.7 billion in 2025.
  • Business Quant data shows Payables for EMN at $2.7 billion in Q4 2025, $2.2 billion in Q3 2025, and $2.4 billion in Q2 2025.